SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Mar-24 4:10 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-24 | Grant | 38,701 | -- | -- | 71% 54.37K to 93.07K | |
05-Jan-24 4:50 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jan-24 | Sale | 5,843 | $29.46 | $172,135.00 | (10%) 60.22K to 54.37K | |
03-Jan-24 5:34 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-24 | Option Exercise | 3,187 | -- | -- | 6% 57.03K to 60.22K | |
03-Mar-23 5:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-23 | Grant | 30,674 | -- | -- | 119% 25.69K to 56.36K | |
06-Jan-23 5:26 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Jan-23 | Sale | 2,574 | $37.21 | $95,778.50 | (9%) 28.26K to 25.69K | |
04-Jan-23 8:33 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-23 | Option Exercise | 3,187 | -- | -- | 13% 25.07K to 28.26K | |
03-Mar-22 8:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-22 | Grant | 13,816 | -- | -- | 126% 10.92K to 24.74K | |
03-Mar-22 8:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Exercise | 3,187 | -- | -- | 36% 8.79K to 11.97K | |
03-Mar-22 8:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Sale | 1,051 | $112.24 | $117,964.00 | (9%) 11.97K to 10.92K | |
09-Nov-21 6:08 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Nov-21 | Option Exercise | 2,400 | $12.62 | $30,288.00 | 28% 8.71K to 11.11K | |
09-Nov-21 6:08 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Nov-21 | Market Option Sale (Planned) | 2,400 | $132.72 | $318,535.00 | (22%) 11.11K to 8.71K | |
15-Oct-21 7:02 PM View: | Intellia Therapeutics, Inc. (NTLA) | 14-Oct-21 | Option Exercise | 2,400 | $12.62 | $30,288.00 | 28% 8.71K to 11.11K | |
15-Oct-21 7:02 PM View: | Intellia Therapeutics, Inc. (NTLA) | 14-Oct-21 | Market Option Sale (Planned) | 2,400 | $128.44 | $308,249.00 | (22%) 11.11K to 8.71K | |
27-Sep-21 4:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 24-Sep-21 | Option Exercise | 7,923 | $12.62 | $99,988.30 | 1002% 0.79K to 8.71K | |
23-Sep-21 10:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 21-Sep-21 | Option Exercise | 2,400 | $12.62 | $30,288.00 | 303% 0.79K to 3.19K | |
23-Sep-21 10:00 PM View: | Intellia Therapeutics, Inc. (NTLA) | 21-Sep-21 | Market Option Sale (Planned) | 2,400 | $149.81 | $359,544.00 | (75%) 3.19K to 0.79K | |
01-Sep-21 7:32 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Option Exercise | 2,400 | $12.62 | $30,288.00 | 303% 0.79K to 3.19K | |
01-Sep-21 7:32 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Market Option Sale (Planned) | 2,400 | $158.04 | $379,300.00 | (75%) 3.19K to 0.79K | |
11-Aug-21 4:50 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Aug-21 | Option Exercise | 2,400 | $12.62 | $30,288.00 | 303% 0.79K to 3.19K | |
11-Aug-21 4:50 PM View: | Intellia Therapeutics, Inc. (NTLA) | 09-Aug-21 | Market Option Sale (Planned) | 2,400 | $164.05 | $393,720.00 | (75%) 3.19K to 0.79K |